| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 17,933 | 10,112 | 17,787 | 1,066 |
| Accounts receivable, net | 1,925 | 2,498 | 1,870 | 1,854 |
| Inventory | 3,491 | 2,987 | 3,187 | 3,042 |
| Prepaid expenses and other current assets | 1,151 | 1,072 | 1,201 | 1,837 |
| Total current assets | 24,500 | 16,669 | 24,045 | 7,799 |
| Property and equipment, net | 620 | 611 | 640 | 683 |
| Operating lease right-of-use assets | 749 | 843 | 935 | 1,024 |
| Other long-term assets | 76 | 41 | 41 | 41 |
| Total assets | 25,945 | 18,164 | 25,661 | 9,547 |
| Accounts payable | 1,359 | 1,143 | 1,345 | 1,157 |
| Accrued expenses and other current liabilities | 3,494 | 2,697 | 2,790 | 1,588 |
| Note payable, current | - | - | - | 1,000 |
| Deferred revenue | 84 | 177 | 106 | 97 |
| Operating lease liabilities - current | 426 | 410 | 394 | 379 |
| Total current liabilities | 5,363 | 4,427 | 4,635 | 4,221 |
| Operating lease liabilities long-term | 362 | 477 | 584 | 687 |
| Total liabilities | 5,725 | 4,904 | 5,219 | 4,908 |
| Series HPreferred Stock | - | - | - | 69,829 |
| Series GPreferred Stock | - | - | - | 8,000 |
| Series EPreferred Stock | - | - | - | 15,900 |
| Series DPreferred Stock | - | - | - | 1,560 |
| Series CPreferred Stock | - | - | - | 2,550 |
| Series BPreferred Stock | - | - | - | 4,319 |
| Series APreferred Stock | - | - | - | 4,850 |
| Series G1Preferred Stock | - | - | - | 9,849 |
| Series F2Preferred Stock | - | - | - | 10,400 |
| Series F1Preferred Stock | - | - | - | 4,600 |
| Series D2Preferred Stock | - | - | - | 8,753 |
| Series D1Preferred Stock | - | - | - | 500 |
| Series C1Preferred Stock | - | - | - | 2,515 |
| Total convertible preferred stock | - | 0 | 0 | 143,625 |
| Common stock, 0.001 par value 300,000,000 shares authorized as of march31, 2026 49,838,867 and 46,865,051 issued and outstanding as of march31, 2026 and december31, 2025, respectively | 50 | 47 | 47 | 2 |
| Additional paid-in capital | 182,868 | 168,878 | 168,666 | 1,362 |
| Accumulated deficit | -162,698 | -155,665 | -148,271 | -140,350 |
| Total stockholders equity | 20,220 | 13,260 | 20,442 | -138,986 |
| Total liabilities and stockholders equity | 25,945 | 18,164 | 25,661 | 9,547 |
CapsoVision, Inc (CV)
CapsoVision, Inc (CV)